Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-01 @ 12:41 PM
Study NCT ID:
NCT03134456
Status:
COMPLETED
Last Update Posted:
2024-12-03
First Post:
2017-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-06
First Submit QC Date:
None
Study First Post Date:
2017-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-29
Last Update Post Date:
2024-12-03
Last Update Post Date Type:
ACTUAL